Cheryl L. Jorcyk - Concepedia

Author

Cheryl L. Jorcyk

Also Known As

C JORCYK, C Jorcyk, C L Jorcyk, C. L. Jorcyk, C.L. Jorcyk, CHERYL L. JORCYK, Cheryl Jorcyk, Cheryl L Jorcyk, Cheryl L. Jorcyk, Jorcyk, Cheryl L.

123

Publications

4.3K

Citations

H-Index

Concepts

All Affiliations

Boise State University National Cancer Institute Frederick National Laboratory for Cancer Research University of Utah Molecular Oncology (United States)

About

Cheryl L. Jorcyk is an author at Boise State University specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	23	1.3K
2	Natural Sciences	3	3	95
3	Engineering	2	2	40
4	Arts	1	1	221
5	Education	1	1	221

Cheryl L. Jorcyk

Publications

Citations

H-Index

Page 1

	Year	Citations
Bleach gel: A simple agarose gel for analyzing RNA quality Patrick S. Aranda, Dollie LaJoie, Cheryl L. Jorcyk Electrophoresis	2012	572
Breast Cancer Cells Stimulate Neutrophils to Produce Oncostatin M: Potential Implications for Tumor Progression Marisa M. Queen, Randall E. Ryan, Ryan G. Holzer, Cancer Research	2005	407
I Just Don't Trust Them: The Development and Validation of an Assessment Instrument to Measure Trust in Science and Scientists Louis S. Nadelson, Cheryl L. Jorcyk, Dazhi Yang, School Science and Mathematics Science Faculty MembersEducational PsychologyEducationResearch EthicsC Ronbach	2014	221
Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors. Alfonso Calvo, Nianqing Xiao, Jason Kang, PubMed Tumor BiologyTranscriptional RegulationOncologyCancer Cell BiologyProstate Cancer Progression	2002	177
Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies Cheryl L. Jorcyk, Ken Tawara, Cheryl L. Jorcyk Cancer Management and Research ImmunologyMetastatic EventsCancer MetastasisOsteoporosisInflammation	2011	134
Isoforms of the human ets-1 protein: generation by alternative splicing and differential phosphorylation. Shigeki Koizumi, Fisher Rj, Shigeki Fujiwara, PubMed	1990	103
Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies Cheryl L. Jorcyk, Ken Tawara, Cheryl L. Jorcyk Cancer Management and Research ImmunologyImmune RegulationCell DeathMetastatic EventsCancer Metastasis	2011	80
The human ETS1 gene: genomic structure, promoter characterization and alternative splicing. Cheryl L. Jorcyk, D K Watson, G J Mavrothalassitis, PubMed	1991	78
Oncostatin M Promotes Mammary Tumor Metastasis to Bone and Osteolytic Bone Degradation C A Bolin, Kuniyoshi Tawara, Carolann Sutherland, Genes & Cancer	2012	75
HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β Ken Tawara, H. Scott, Jacqueline Emathinger, Oncotarget	2019	66

Page 1